Dianthus Therapeutics, Inc. (DNTH)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$108.10+0.23%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · DNTH
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 18.5 | 2.0 | 6.2 | 2.8 | 6.4 | 1.5 | — | 0.0 | 0.0 |
| Total Revenues | — | 2.0 | 6.2 | 2.8 | — | — | — | 0.0 | 0.0 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 175.6 | 145.6 | 83.1 | 32.8 | 29.4 | 12.6 | 50.6 | 59.2 | 41.3 |
| Operating Income | (217.8) | (177.9) | (101.9) | (48.2) | (29.7) | (13.1) | (78.7) | (83.0) | (60.0) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.2 |
| Interest & Investment Income | 16.7 | 10.0 | 11.3 | 3.3 | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 25.6 | 15.6 | 16.9 | 4.6 | 1.2 | (0.0) | — | — | 2.4 |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||
| Net Income | (192.2) | (162.3) | (85.0) | (43.5) | (28.5) | (13.1) | (74.9) | (76.8) | (57.5) |
| Per Share | |||||||||
| Basic EPS | (3.43) | (4.20) | (2.55) | (8.45) | (32.57) | (15.01) | (1.71) | — | — |
| Diluted EPS | (3.43) | (4.20) | (2.55) | (8.45) | (32.57) | (15.01) | (1.71) | — | — |
| Revenue per Share | 0.33 | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.00 | — | — | — | — | — |
| Basic Weighted Avg Shares | 56.0 | 38.6 | 33.3 | 5.2 | 0.9 | 0.9 | 43.9 | — | — |
| Diluted Weighted Avg Shares | 56.0 | 38.6 | 33.3 | 5.2 | 0.9 | 0.9 | 43.9 | — | — |
| Supplemental | |||||||||
| EBITDA | — | — | — | — | (27.8) | (11.1) | (76.7) | (81.1) | (59.1) |
| EBIT | (217.8) | (177.9) | (101.9) | (48.2) | (29.7) | (13.1) | (78.7) | (83.0) | (60.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.